Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins
Open Access
Abstract
(1) Background: Human adrenomedullin (hAM) is a hypotensive peptide hormone that exerts powerful anti-inflammatory effects. AM also had therapeutic effects in various animal experimental models of disease. However, treatment required continuous administration as the half-life of native AM is short in blood. To resolve this, we developed four human IgG1 and IgG4 Fc-fusion proteins containing full-length hAM or hAM residues 6-52. (2) Methods: We used mammalian cells to produce recombinant Fc-AM derivatives and tested the pharmacokinetics and biological activity of Fc-AM. (3) Results: We developed four Fc-fusion AMs (Fc-AM), which are long-acting AM derivatives in mammalian cells. Fc-AM had a prolonged half-life in blood and retained its ability to bind to the AM1 receptor. Fc-AM (6-52) induced higher cAMP levels for the receptor than Fc-AM. After the administration of IgG1-AM (6-52) or IgG4-AM (6-52) to rats, tissue transfer to the kidney and small intestine was observed. In addition, treatment with IgG4-AM (6-52) inhibited blood pressure increase in spontaneously hypertensive rats. (4) Conclusions: Fc-AM produced from mammalian cells can be easily prepared and might be an effective novel therapeutic agent.Keywords
Funding Information
- Japan Agency for Medical Research and Development (A513)
This publication has 31 references indexed in Scilit:
- Biological properties of adrenomedullin conjugated with polyethylene glycolPeptides, 2014
- Mammalian cell protein expression for biopharmaceutical productionBiotechnology Advances, 2012
- Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodiesmAbs, 2011
- Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion proteinDiabetes/Metabolism Research and Reviews, 2010
- “Inclonals”mAbs, 2009
- Adrenomedullin Administration Immediately After Myocardial Infarction Ameliorates Progression of Heart Failure in RatsCirculation, 2004
- Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humansBritish Journal of Clinical Pharmacology, 2001
- Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both PartnersJournal of Biological Chemistry, 2001
- Visualization of the Calcitonin Receptor-like Receptor and Its Receptor Activity-modifying Proteins during Internalization and RecyclingJournal of Biological Chemistry, 2000
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993